Renal Cancer - Results from #8900

Safety of presurgical targeted therapy in the setting of metastatic renal cell carcinoma - Abstract June 23, 2011

Efficacy of sunitinib re-exposure after failure of an mTOR inhibitor in patients with metastatic RCC - Abstract June 23, 2011

The outcome of patients treated with sunitinib prior to planned nephrectomy in metastatic clear cell renal cancer - Abstract June 22, 2011

Small renal mass: What the urologist needs to know for treatment planning and assessment of treatment results - Abstract June 21, 2011

Pioglitazone, etoricoxib, interferon-α, and metronomic capecitabine for metastatic renal cell carcinoma: Final results of a prospective phase II trial - Abstract June 21, 2011

Differential genetic expression in large versus small clear cell renal cell carcinoma: Results from microarray analysis - Abstract June 21, 2011

Clear-cell papillary renal cell carcinoma: Molecular and immunohistochemical analysis with emphasis on the von Hippel-Lindau gene and hypoxia-inducible factor pathway-related proteins - Abstract June 20, 2011

Renal cell carcinoma: What the surgeon and treating physician need to know - Abstract June 20, 2011

Chromophobe renal cell carcinoma in Iceland: An epidemiological and clinicopathological study - Abstract June 19, 2011

Patient outcome and prognostic factors of renal cell carcinoma in clinical stage T(1-3)N(1-2)M(0): A single-institution analysis - Abstract June 17, 2011

Chromophobe renal cell carcinoma: A clinicopathologic study of 203 tumors in 200 patients with primary resection at a single institution - Abstract June 17, 2011

Familial renal cell carcinoma from the Swedish Family-Cancer Database - Abstract June 16, 2011

A specific gene expression signature characterizes metastatic potential in clear cell renal cell carcinoma - Abstract June 16, 2011

Angiotensin system inhibitors and outcome of sunitinib treatment in patients with metastatic renal cell carcinoma: A retrospective examination - Abstract June 16, 2011

Sequential use of sorafenib and sunitinib in advanced renal-cell carcinoma (RCC): An Italian multicentre retrospective analysis of 189 patient cases - Abstract June 15, 2011

How often are patients with diabetes or hypertension being treated with partial nephrectomy for renal cell carcinoma? A population-based analysis - Abstract June 15, 2011

Tumor control outcomes after hypofractionated and single-dose stereotactic image-guided intensity-modulated radiotherapy for extracranial metastases from renal cell carcinoma - Abstract June 14, 2011

An adjusted indirect comparison of everolimus and sorafenib therapy in sunitinib-refractory metastatic renal cell carcinoma patients using repeated matched samples - Abstract June 14, 2011

BJUI Mini Reviews - Adverse events from targeted therapies in advanced renal cell carcinoma: The impact on long-term use June 14, 2011

NCCN Task Force report: Optimizing treatment of advanced renal cell carcinoma with molecular targeted therapy - Abstract June 13, 2011

Page 446 of 455